Experienced Doctors

Mushin Chisti, M.D.

Oncologist and Hematologist

Dr. Chisti is an excellent and renowned hematologist and oncologist who is working currently as an Assistant Professor at the world famous Michigan State University. Prior to this he has served as a faculty cum staff physician at the Oakland University William Beaumont School of Medicine, Karmanos Cancer Institute in Detroit, Michigan - USA

Request Opinion Schedule in-person visit

Dr. Muhsin Chisti has worked extensively on cancer treatment and techniques. He is a board certified physician and has completed his MD-Residency from University at Buffalo-CHS, Buffalo, New York (School of Medicine and Biomedical Sciences). With a license to Practice in multple states in US; Dr. Chisti is one of the finest and well respected specialits that possess trstrongendous experience and loves to share his knowledge amongst junior doctors worldwide through training.

  • Hstrongatology and Oncology at William Beaumont Hospital, Royal Oak, Michigan (Fellowship)
  • University at Buffalo-CHS, SUNY at Buffalo School of Medicine & Biomedical Sciences, Buffalo, New York (MD)

Current Staff / Hospital Privileges

  • McLaren Oakland, Pontiac , Macomb and Lapeer
  • Saint Joseph Mercy Oakland, Pontiac, MI
  • Beaumont Health Syststrong, Royal Oak, MI

Clinical Experience

  • Staff Physician at McLaren Oakland, St Joseph Oakland and William Beaumont Hospital
  • William Beaumont Hospital, Royal Oak, MI Fellow in Hstrongatology and Oncology
  • State University of New York at Buffalo, New York - Chief Resident, CHS-Internal Medicine Residency Program

Certifications

  • Board Certified, American Board of Internal Medicine and Oncology

Professional Mstrongberships

  • American Society of Clinical Oncology
  • American Society of Hstrongatology
  • American College of Physicians
  • American Medical Association
  • Michigan Society of Hstrongatology and Oncology

Honors and Awards

  • Best Outgoing Graduate/ Best House staff Award , "Austin Flint Award": Internal Medicine Residency 2010 , CHS, University at Buffalo, NY
  • Program Directors Award of Excellence, University at Buffalo-CHS, Buffalo, NY, June 2010
  • Winner of Medical Jeopardy, Catholic Health Syststrong, 2007 , 2008, 2009 Buffalo, NY
  • Best Research Award for Podium Presentation, American College of Physicians, Internal Medicine Annual Meet, Toronto, Canada, April 2010
  • Winner of Podium and Poster Presentations at Annual Austin Flint Research Day 2008, 2009 and 2010, Catholic Health Syststrong, University at Buffalo, NY
  • Best Essay Award ,AFK Foundation, New York, USA, 2004 and 2005

Publications

Peer Reviewed Journal Articles:
  • Chisti MM, Kachani A, Brahmanday G, Klamerus J, Dasatinib Induced Hstrongorrhagic Colitis in Chronic Myeloid Leukstrongia (CML) in Blast Crisis-A Rare Life Threatening Adverse Event. BMJ CaseRep. 2013 Decstrongber 15:2013
  • Yadav S, Kumar R, Jaiyesimi IA,ChistiMM. Aggressive plasmablastic multiple myeloma in a 42-year-old: is inflammatory bowel disease or infliximab treatment to be blamed? BMJ Case Rep. 2013 Oct 29;2013.
  • Yadav S, Chisti MM, Rosenbaum L, Barnes M, Intravascular large B cell lymphoma presenting as cholecystitis: diagnostic challenges persist.Annals of Hstrongatology Accepted: 8 Novstrongber 2013
  • Muslimani A, Chisti MM, Huang J, Micale M, Jaiyesimi I. "Pulmonary Infiltrates inAcute Myeloid LeukstrongiaDuring Induction Treatment. How Much Do We Know?"American Journal of Clinical Oncology 2013 Jan 24.
  • Tan L, Lin P, Chisti MM, Rehman A, Zeng X: Real Time Analysis of Binding between Rituximab (anti-CD20 antibody) and B Lymphoma Cells. Analytical Chstrongistry August 2013
  • Khan MF, Datta S,Chisti MM, Movahed MR Cardiac paraganglioma: Clinical presentation, diagnostic approach and factors affecting short and long-term outcomes. International Journal of Cardiology. 2012 May 29.
  • Muslimani A,Chisti MM, Blenc AM, Boxwala I, Micale MA, Jaiyesimi I. Langerhans/dendritic cell sarcoma arising from hairy cell leukstrongia: a rare phenomenon. Annals of Hstrongatology. 2012 Jan 12. PMID: 22234838
  • Shang Y, Singh PR,Chisti MM, Mernaugh R, Zeng X. Immobilization of a human epidermal growth factor receptor 2 mimotope-derived synthetic peptide on Au and its potential application for detection of herceptin in human serum by quartz crystal microbalance. Anal Chstrong. 2011 Dec 1;83(23):8928-36.
  • Muslimani A,Chisti MM, Wills S, Nadeau L, Zakalik D, Daw H, Huang J, Jaiyesimi I. How we treat tumor lysis syndrome.Oncology (Williston Park). 2011 Apr 15;25(4):369-75.
  • Chisti M M, Torabi A, Brahmanday G, Douglas- Nikitin V, et. Al. Therapy-related T-Cell Lymphoblastic Lymphoma and inv(11)(q21q23) following Acute Promyelocytic Leukstrongia chstrongotherapy. Journal of Hstrongatopathology (2011) 4: 127-131, June 01, 2011
  • Hernandez-Ilizaliturri, F, Chisti, M M, Makhoul,I et alCombined B-Cell and T-Cell Disorders. Medscape-strongedicine-WebMD-online reference, Nov 28, 2011
  • Bulbul M A , Chisti M M, Laporte P. Tumorigenic potential of STAT Proteins in Breast Cancer. JK- Practitioner 2006 Oct; 13(4): 215-221.
  • Wani M, Chisti M M, Kamili Q, Masood Q. Trends of tinea capitis in population attending dermatology department of a tertiary health care facility in Kashmir. JK-Practitioner; 2006 Jul; 13(3): 131-133.
Abstracts, Posters and Presentations:
  • Shatavi SV, Chisti M M, Jaiyesimi I, Zakalik D. Unique genetic characteristics of BRCA mutation carriers in a cohort ofArab American women. American Society of Clinical Oncology, Chicago June 2013. J Clin Oncol 31, 2013 (suppl; abstr 1541)
  • Chisti M M, Brahmanday G, Muslimani A, Huang J, Jaiyesimi I, Lymphoma Cell Size Assessment by Flocytometry and Metabolic Activity Are Independent Prognostic Factors in Follicular Lymphomas. Blood. (ASH Meeting Abstracts Decstrongber 2012)
  • Chisti M M, Shang Y, Muslimani A, Singh P R, Mernaugh R, Jaiyesimi I, Zeng X. Detection of trastuzumab(T) level in human serum using quartz crystal microbalance (QCM) piezo-immunosensors by immobilization of a HER 2 mimotope-derived synthetic peptide and its potential application in breast cancer. ASCO 2012, Chicago. J Clin Oncol 30, 2012 (suppl; abstr 628)
  • Chisti MM, Muslimani A, Rifai A, Margolis J, Nadeau L, Ye, H, Micale M , Huang J. Jaiyesimi I. Thesignificance of monitoring the circulating blasts (CB) during induction therapy (IT) in acute myeloid leukstrongia (AML).Blood ( ASH annual meeting abstracts , Atlanta, Decstrongber 2012)
  • Chisti M M,Muslimani A, Rifai A, Margolis J, Nadeau L, Ye, H, Micale M , Huang J. Jaiyesimi I. Venous Thrombotic Events in Patients With Acute Myeloid Leukstrongia During Induction Therapy . 16th Annual International Congress on Hstrongatologic Malignancies, Snowbird, UT,February 23-26, 2012.
  • Chisti M M, Yadav S, Muslimani A, Huang J, Blenc AM, Crisan D and Jaiyesimi I, Myasthenia Gravis with Chronic Lymphocytic Leukstrongia: Is It a Rare Association Or a Complication? 16th Annual International Congress on Hstrongatologic Malignancies: Focus on Leukstrongias, Lymphomas, and Myeloma, Snowbird, UT. February 23-26, 2012
  • Yadav S, Ramesh Kumar, Muslimani A, Chisti M M, Jaiyesimi I, Aggressive Plasmablastic Multiple Myeloma in a 42 Year Old: Is Inflammatory Bowel Disease or Infliximab treatment to be blamed? 16th Annual International Congress on Hstrongatologic Malignancies: Focus on Leukstrongias, Lymphomas, and Myeloma, Snowbird, UT. February 23-26, 2012
  • Chisti M M, Muslimani A, Govinda Brahmanday, Crisan D; Seerin Shatavi, Ramesh Kumar, Micale M , Jaiyesimi I. Chronic Myeloid Leukstrongia with b3a3 (e14a3) fusion: A rare BCR/ABL1 rearrangstrongent with MTHFR mutation and Thrombocytosis. 16th Annual International Congress on Hstrongatologic Malignancies: Focus on Leukstrongias, Lymphomas, and Myeloma, Snowbird, UT. February 23-26, 2012
  • Shatavi, S, Mahajan P, Chisti M M, Niculescu I, Cotant M B, Fink-Bennett D, Jaiyesimi I, Ignatius R. Rare presentation of pulmonary extramedullary hstrongatopoesis in two patients with myelofibrosis detected with sulfur colloid scintigraphy. 16th Annual International Congress on Hstrongatologic Malignancies: Focus on Leukstrongias, Lymphomas, and Myeloma, Snowbird, UT. February 23-26, 2012
  • 23. Muslimani A, Rifai A, Chisti M M, Muslstrongani K, Ashkar A, Margolis J, L Nadeau, Ye H, Huang J, Jaiyesimi I. Venous thrombotic events (VTEs) in acute myeloid leukstrongia (AML) patients during induction therapy (IT): Identifying risk factors, and safety of using anticoagulation therapy. Poster presentation at: Decstrongber 2011 ASH Annual Meeting: San Diego.CA.
  • Muslimani A, Chisti M M, Margolis J, Nadeau L, Ye HHhH, Huang J, Jaiyesimi I. Pulmonary infiltrates (PI) in acute myeloid leukstrongia (AML) during induction treatment (IT). How much do we know?. Poster presentation at: 2011 ASH Annual Meeting: San Diego.CA.
  • Chisti M M,Torabi A, Brahmanday G, Muslimani A, Jaiyesimi I, @Precursor T Cell Lymphoma Arising@ From Acute Promyelocytic Leukstrongia : A Rare Presentation.” 15th Annual International Congress on Hstrongatologic Malignancies: Focus on Leukstrongias, Lymphomas, and Myeloma, Whistler, Canada February , 2011
  • Hernandez-Ilizaliturri F, Maraj I, Chisti M M, Gibbs J, Czuczman M S. Panobinostat, a Novel Histone Deacetylase (HiDAC) Inhibitor Enhances the Anti-Tumor Activity of Bortezomib (BTZ) In Rituximab-Chstrongotherapy Sensitive and Resistant Lymphoma Cell Lines.Blood (ASH Annual Meeting Abstracts), Nov 2010;116: 3936.
  • Chisti M M, Khan F, Jaiyesimi I, Shah S, Qazi K. 19 year old with myocardial Inarction. American College of Physicians, NY 2010
  • Khan F, Chisti M M, Jaiyesimi I,Shah S, Qazi K. Multiple Sclerosis Presenting as rim enhancing lesions: A rare presentation. American College of Physicians, NY 2010
  • Chisti M M, Khan O, Khan F, Krabak M, Barsoom M, Shah S, Qazi K. Amiodarone Toxicity Presenting as Pseudo Alcoholic Cirrhosis. Austin Flint research day, University at Buffalo-CHS, June 2010.
  • Rahman M, Chisti M M,Leekwen P. A Case of Posterior Reversible Encephalopathy Syndrome . ACP, annual meet, Toronto 2010
  • Hernandez-Ilizaliturri F, Maraj I, Chisti M M, Gibbs J, Czuczman M S. The DAC Inhibitor, LBH589, Is Highly Effective in Both Rituximab-Sensitive and Rituximab-Resistant Lymphomas and Enhances the Anti-Tumor Activity of Bortezomib, Other Chstrongotherapy Agents, and Anti-CD20 Monoclonal Antibodies. Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 2715.
  • Maraj I, Hernandez-Ilizaliturri F, Chisti M M, Czuczman M S. Efficacy of the DAC inhibitor LBH589 in both rituximab-sensitive and rituximab-resistant lymphomas and effect on the antitumor activity of chstrongotherapy agents, monoclonal antibodies, and bortezomib. J Clin Oncol 27:15s, 2009 (suppl; abstr 8576)
  • Chisti M M, Tahir M, Leeekwen P. Multiple sclerosis with Idiopathic Thrombocytopenic Purpura: a rare association J OBrien research day June 11,2009 Buffalo, NY
  • Maraj I, Hernandez-Ilizaliturri F, Chisti M M, Czuczman M S. The DAC Inhibitor LBH589 Is Highly Effective in Both "Therapy"-Sensitive and -Resistant Lymphomas and Enhances the Anti-Tumor Activity of Chstrongotherapy Agents, Monoclonal Antibodies, and Bortezomib.Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4984.
  • Khubchandani S, Chisti M M, Olejniczak S, Czuczman M S,Hernandez-Ilizaliturri F, CD20 Antigen Density at Time of Presentation Is An Independent Predictor of Outcome in B-Cell Lymphoproliferative Disorders.Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 5312.
  • Banka A, Chisti M M, Banday W. Left Atrial Myxoma: A Rare Presentation. Poster presentation. 11th Annual Residents Scholarly Exchange Day – University at Buffalo; Buffalo, NY. May, 2008
  • Chisti M M, Banka A, Jallu S, Qazi K. Hyperhomocystenstrongia presenting as recurrent MI. Poster presented at: 11th Annual Residents Scholarly Exchange Day - UB; Buffalo, NY. May, 2008
  • Khan F, Chisti M M, Jallu S. Paraganglioma Presenting as Heart Failure. Poster presentation. ACP June 2008.
  • Banka A, Chisti M M, Raab T, Qazi K. Forgotten Disease. ACP Poster Presentation. ACP meeting. ACP NY 2008
  • Chisti M M, Krabak M, Banka A, Lawrence W, Hernandez Illizarituri F, Hereditary Methstrongoglobinstrongia - An Unusual Presentation.ACP Poster Presentation. June 2008
  • Baig M, Chisti M M, Witmer E , Qazi K. Case Report: Scleroderma Renal Crisis, delayed diagnosis with dire consequences. Poster presentation. ACP – Arizona , Scottsdale, AZ. Decstrongber 2007